Statistics for RenovoRx, (id:5943 RNXT)
Valuation metrics
Market cap
30.96M
Enterprise value
14.40M
Trailing P/E (ttm)
-1.30
Forward P/E
-3.15
PEG ratio
-3.15
Price/Sales (ttm)
Price/Book (mrq)
4.55
Enterprise Value/Revenue
Enterprise Value/EBITDA
-1.10
Overview
Shares outstanding
24.00M
Float
23.53M
Shares short
71.85K
% Held by insiders
0.02%
% Held by institutions
0.08%
Average volume (10 days)
91.38K
Average volume (90 days)
Price summary
52-Week low
0.53
52-Week high
2.35
52-Week change
46.51%
Beta
0.99
50-Day moving average
1.04
200-Day moving average
1.20
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-70.08%
Return on equity
-155.12%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
0.00
Net income to common (ttm)
-8,113,000.00
Diluted EPS (ttm)
-0.58
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
11.74M
Total cash per share (mrq)
0.49
Total debt (mrq)
0.00
Total Debt/Equity (mrq)
0.00
Current ratio (mrq)
915.60%
Book value per share (mrq)
-0.28
Cash flow
Cash flow statement
-9,282,000.00
Levered free cash flow (LFCF)
-5,617,750.00